Zobrazeno 1 - 10
of 114
pro vyhledávání: '"James NA"'
Autor:
Cato C. Loeff, Willemijn van Gemert, Bastiaan M. Privé, Inge M. van Oort, Rick Hermsen, Diederik M. Somford, James Nagarajah, Linda Heijmen, Marcel J. R. Janssen
Publikováno v:
EJNMMI Reports, Vol 8, Iss 1, Pp 1-14 (2024)
Abstract Aim The objective of this study was to compare the detection rates of [18F]PSMA-1007 and [18F]Fluciclovine in early biochemical recurrence (BCR) of prostate cancer, i.e. with low prostate-specific antigen (PSA) levels (0.2–5.0 µg/L). Meth
Externí odkaz:
https://doaj.org/article/4e171fc0090c4eb5a269193436755dec
Autor:
Pepijn van Houten, James Nagarajah, Janneke E W Walraven, Martin Jaeger, Adriana C H van Engen-van Grunsven, Johannes W Smit, Romana T Netea-Maier
Publikováno v:
European Thyroid Journal, Vol 13, Iss 4, Pp 1-9 (2024)
Objective: Patients with non-medullary thyroid carcinoma (NMTC) that are refractory to radioactive iodine (RAI) have a poor prognosis. Strategies for restoring the ability to take up iodine, so-called redifferentiation, are promising but not suitable
Externí odkaz:
https://doaj.org/article/8b42edffa11040c7b13500980dea3948
Autor:
Lachlan P. Deimel, Lucile Moynié, Guoxuan Sun, Viliyana Lewis, Abigail Turner, Charles J. Buchanan, Sean A. Burnap, Mikhail Kutuzov, Carolin M. Kobras, Yana Demyanenko, Shabaz Mohammed, Mathew Stracy, Weston B. Struwe, Andrew J. Baldwin, James Naismith, Benjamin G. Davis, Quentin J. Sattentau
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-12 (2024)
Abstract Many archetypal and emerging classes of small-molecule therapeutics form covalent protein adducts. In vivo, both the resulting conjugates and their off-target side-conjugates have the potential to elicit antibodies, with implications for all
Externí odkaz:
https://doaj.org/article/cfce8b6432ac440bba75dc9b6023863a
Autor:
Gabrielle N. Swartz, BS, Sandeep S. Bains, MD, DC, MBA, Jeremy A. Dubin, BA, Reza Katanbaf, MD, MBA, Hunter Hayes, DO, James Nace, DO, MPT, Michael A. Mont, MD, Ronald E. Delanois, MD
Publikováno v:
Arthroplasty Today, Vol 30, Iss , Pp 101473- (2024)
Background: As the use of robotics in total hip arthroplasty (THA) continues to gain popularity, differences in clinical outcomes when compared to manual techniques have remained unclear. This study aimed to compare postoperative complications betwee
Externí odkaz:
https://doaj.org/article/1c230c8f422c44e29eae0c748b9fca34
Autor:
Sandeep S. Bains, MD, DC, MBA, Jeremy A. Dubin, BA, Christopher G. Salib, MD, Rubén Monárrez, MD, Ethan Remily, DO, Daniel Hameed, MD, Gabrielle N. Swartz, BS, Reza Katanbaf, MD, MBA, James Nace, DO, MPT, Ronald E. Delanois, MD
Publikováno v:
Arthroplasty Today, Vol 30, Iss , Pp 101517- (2024)
Background: The number of revision total hip arthroplasties (THAs) is projected to reach 572,000 cases annually by 2030 in the United States. This may be attributed to the successes of primary THAs combined with an aging population, patients desire t
Externí odkaz:
https://doaj.org/article/7a10e575c07b41a3876a6b365d29b2d8
Autor:
Dagmar Grob, Bastiaan M. Privé, Constantijn H. J. Muselaers, Niven Mehra, James Nagarajah, Mark W. Konijnenberg, Steffie M. B. Peters
Publikováno v:
EJNMMI Physics, Vol 11, Iss 1, Pp 1-12 (2024)
Abstract Background Bone marrow toxicity in advanced prostate cancer patients who receive [177Lu]Lu-PSMA-617 is a well-known concern. In early stage patients; e.g. low volume metastatic hormone sensitive prostate cancer (mHSPC) patients, prevention o
Externí odkaz:
https://doaj.org/article/6dbce80e4d6b49a5afe0d91156498091
Autor:
Sandeep S. Bains, Jeremy A. Dubin, Daniel Hameed, Zhongming Chen, Mallory C. Moore, Ashesh Shrestha, James Nace, Ronald E. Delanois
Publikováno v:
Arthroplasty, Vol 6, Iss 1, Pp 1-7 (2024)
Abstract Purpose The gold standard to decrease total joint arthroplasty (TJA) periprosthetic joint infection (PJI) is preoperative antibiotic prophylaxis. Despite substantial prevention efforts, rates of PJIs are increasing. While cefazolin is the dr
Externí odkaz:
https://doaj.org/article/b9cf335bdc6649a0ac7a84859216c167
Autor:
Kalijn F. Bol, Gerty Schreibelt, Martine Bloemendal, Wouter W. van Willigen, Simone Hins-de Bree, Anna L. de Goede, Annemiek J. de Boer, Kevin J. H. Bos, Tjitske Duiveman-de Boer, Michel A. M. Olde Nordkamp, Tom G. M. van Oorschot, Carlijn J. Popelier, Jeanne M. Pots, Nicole M. Scharenborg, Mandy W. M. M. van de Rakt, Valeska de Ruiter, Wilmy S. van Meeteren, Michelle M. van Rossum, Sandra J. Croockewit, Bouke J. Koeneman, Jeroen H. A. Creemers, Inge M. N. Wortel, Caroline Angerer, Mareke Brüning, Katja Petry, Andrzej Dzionek, Astrid A. van der Veldt, Dirk J. van Grünhagen, Johanna E. M. Werner, Johannes J. Bonenkamp, John B. A. G. Haanen, Marye J. Boers-Sonderen, Rutger H. T. Koornstra, Martijn F. Boomsma, Erik H. J. Aarntzen, Martin Gotthardt, James Nagarajah, Theo J. M. de Witte, Carl G. Figdor, Johannes H. W. de Wilt, Johannes Textor, Jan Willem B. de Groot, Winald R. Gerritsen, I. Jolanda M. de Vries
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-10 (2024)
Abstract Autologous natural dendritic cells (nDCs) treatment can induce tumor-specific immune responses and clinical responses in cancer patients. In this phase III clinical trial (NCT02993315), 148 patients with resected stage IIIB/C melanoma were r
Externí odkaz:
https://doaj.org/article/245269452ff04a81b46a9a6846fb6516
Autor:
Lachlan P. Deimel, Lucile Moynié, Guoxuan Sun, Viliyana Lewis, Abigail Turner, Charles J. Buchanan, Sean A. Burnap, Mikhail Kutuzov, Carolin M. Kobras, Yana Demyanenko, Shabaz Mohammed, Mathew Stracy, Weston B. Struwe, Andrew J. Baldwin, James Naismith, Benjamin G. Davis, Quentin J. Sattentau
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-2 (2024)
Externí odkaz:
https://doaj.org/article/836c4e00b4f84b94874a2256fdbc25ff
Autor:
Jeremy A. Dubin, BA, Sandeep S. Bains, MD, Daniel Hameed, MD, Rubén Monárrez, MD, Ruby Gilmor, DO, Zhongming Chen, MD, James Nace, DO, Ronald E. Delanois, MD
Publikováno v:
JBJS Open Access, Vol 9, Iss 2 (2024)
Background:. Vulnerable populations, including patients from a lower socioeconomic status, are at an increased risk for infection, revision surgery, mortality, and complications after total joint arthroplasty (TJA). An effective metric to quantify an
Externí odkaz:
https://doaj.org/article/4d7a77a45e5a41ba81d1c794c5f6566b